Counteract Tablet
Product Images NDC 54473-166

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Counteract (NDC 54473-166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Melaleuca, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Of Blister (Allergyblister)

Image Of Blister (Allergyblister)
This is a description of a medicine called Loratadine. The medicine contains 10 mg of Loratadine per tablet. The tablets are provided in a foil packaging with instructions to push the tablet through the foil. The tablets are distributed by Melaleuca in Idaho Falls, USA. The product has a lot number and an expiration date. However, the text appears to be multiple duplicates of the same information.*
FDA Label Image

Image Of Carton (Allergybox)

Image Of Carton (Allergybox)
CounterAct Loratadine Tablets provide temporary relief of indoor and outdoor allergy symptoms such as itchy, watery eyes and itching of the nose or throat. It contains 10mg of antihistamine and is safe for adults and children over 6 years old. Users with liver or kidney disease must consult with a doctor before use. It is important not to exceed one tablet daily as taking more than directed may cause drowsiness. Persons who had a history of allergic reactions to this product should avoid using it. In case of overdose, immediately seek medical help or contact a Poison Control Center. This product is distributed by Melaleuca, Inc and is not available for resale in Canada.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.